(Q41104356)

26 September 2017

1 reference

title

Advanced prostate cancer. Endocrine therapies and palliative measures (English)

1 reference

26 September 2017

M Taub

1

1 reference

26 September 2017

A Begas

series ordinal

2

1 reference

26 September 2017

N Love

series ordinal

3

1 reference

26 September 2017

language of work or name

English

0 references

publication date

1 September 1996

1 reference

26 September 2017

Postgraduate Medicine

1 reference

26 September 2017

100

1 reference

26 September 2017

3

1 reference

26 September 2017

139-40, 143-6, 152 passim

1 reference

Patients' choice of treatment in stage D prostate cancer

26 September 2017

1 reference

https://api.crossref.org/works/10.3810%2FPGM.1996.09.74

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.1996.09.74

The use of strontium 89 forpalliation of pain from bone metastases associated with hormone-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.1996.09.74

Suramin, an active drug for prostate cancer: interim observations in a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.1996.09.74

Leuprolide versus diethylstilbestrol for metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.1996.09.74

Controversies in the treatment of metastatic prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.1996.09.74

21 January 2018

Identifiers

DOI

10.3810/PGM.1996.09.74

1 reference

26 September 2017

1 reference